Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$20.9M Sell
86,556
-1,709
-2% -$377K 0.14% 131
2019
Q3
$17.1M Sell
88,265
-6,910
-7% -$1.33M 0.13% 147
2019
Q2
$17.6M Buy
95,175
+5,294
+6% +$948K 0.13% 134
2019
Q1
$17.1M Buy
89,881
+3,747
+4% +$716K 0.14% 133
2018
Q4
$16.8M Buy
86,134
+2,691
+3% +$525K 0.16% 113
2018
Q3
$17.3M Buy
83,443
+18,900
+29% +$3.72M 0.17% 102
2018
Q2
$11.9M Sell
64,543
-4,719
-7% -$835K 0.16% 121
2018
Q1
$11.8M Sell
69,262
-3,872
-5% -$711K 0.16% 122
2017
Q4
$12.7M Buy
73,134
+7,865
+12% +$1.39M 0.17% 113
2017
Q3
$12.2M Buy
65,269
+3,188
+5% +$565K 0.19% 105
2017
Q2
$10.7M Buy
62,081
+5,241
+9% +$852K 0.19% 112
2017
Q1
$9.33M Buy
56,840
+5,024
+10% +$835K 0.19% 118
2016
Q4
$7.58M Buy
51,816
+16,160
+45% +$2.43M 0.17% 129
2016
Q3
$5.95M Sell
35,656
-576
-2% -$97.4K 0.14% 160
2016
Q2
$5.51M Buy
+36,232
New +$5.63M 0.14% 159

Other funds holding AMGN

Advisor Group's AMGN Position: Q4 2019 in Review

Advisor Group reduced its Amgen (AMGN) stake by 1.9% in Q4 2019, selling an estimated $377K and leaving 86,556 shares worth $20.9M. The position accounts for 0.14% of the portfolio, ranked #131.

Advisor Group first reported a position in AMGN in Q2 2016 and has held it in 15 quarters since. 2,107 funds tracked by Wall St. Rank hold AMGN as of Q4 2019.

  • Advisor Group held 86,556 shares of Amgen worth $20.9M as of Q4 2019.
  • Advisor Group sold 1,709 Amgen shares in Q4 2019, an estimated $377K.
  • Amgen made up 0.14% of Advisor Group's portfolio in Q4 2019, its #131 holding.
  • Advisor Group first reported a position in Amgen in Q2 2016 and has held it in 15 quarters since.
  • 2,107 funds tracked by Wall St. Rank held Amgen as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.